Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlorella vulgaris
- Development stage
- Phase 3
- Lead developer
- Cardinal Tien Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
*Chlorella vulgaris* is a species of unicellular green microalgae that is widely utilized as a bioactive dietary supplement and nutraceutical due to its high content of proteins, chlorophyll, carotenoids, and essential micronutrients. In clinical research, it has been investigated for its ability to modulate oxidative stress, inflammation, and metabolic pathways. Studies have evaluated its efficacy as an adjunctive treatment for major depressive disorder (MDD), where it may alleviate physical and cognitive symptoms, and for obstructive pulmonary diseases such as COPD and asthma, where it enhances systemic antioxidant capacity. Additionally, *Chlorella vulgaris* is studied for its potential to reduce markers of muscle damage (e.g., creatine kinase) following strenuous exercise and for its hypoglycemic properties in patients with type 2 diabetes, likely mediated through the activation of PPAR gamma receptors and increased glucose uptake in peripheral tissues.
- Brand names
- Sun ChlorellaKyochlorellaChina Chlorella
- Other names
- ChlorellaC. vulgarisCVEChlorella vulgaris extract
02
Targets
PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on chlorella vulgaris.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlorella vulgaris.